Results of a recent study provided no evidence supporting the theory that high levels of vitamin D may prevent the risk of prostate cancer.
In the study, serum concentrations of 25-hydroxyvitamin D were measured in 652 prostate-cancer cases and 752 controls. Conditional logistic regression models were used to calculate odds ratios for prostate cancer risk in relation to serum 25-hydroxyvitamin D. No significant association was found between 25-hydroxyvitamin D and risk of prostate cancer.
Source:
American Journal of Epidemiology: Serum Vitamin D And Risk Of Prostate Cancer In A Case-Control Analysis Nested Within The European Prospective Investigation Into Cancer And Nutrition (EPIC)
